
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
15 Outrageous Cosplay Outfits That Will Blow You Away - 2
Picking the Right Doctor prescribed Medication Inclusion in Senior Protection. - 3
Vote In favor of Your Favored Web-based Venture Stage - 4
Examination In progress into Abuse of Japanese Government-Supported Advance - 5
One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
Must-See Attractions in Australia
Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
The most effective method to Keep up with Proficient Handshakes in a Computerized World
Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices
CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting
It's official: NASA's Artemis 2 moon mission will break humanity's all-time distance record
Reports: Germany plans expansion of foreign intelligence powers
New movies to watch this weekend: See 'The Drama' in theaters, rent 'Wuthering Heights,' stream 'Pizza Movie' on Hulu
The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget













